Literature DB >> 25269626

Identification of chemoradiation-resistant osteosarcoma stem cells using an imaging system for proteasome activity.

Keisuke Tamari1, Kazuhiko Hayashi1, Hideshi Ishii2, Yoshihiro Kano2, Masamitsu Konno2, Koichi Kawamoto2, Naohiro Nishida2, Jun Koseki3, Takahito Fukusumi2, Shinichiro Hasegawa2, Hisataka Ogawa2, Atsushi Hamabe2, Masaaki Miyo2, Kozo Noguchi2, Yuji Seo1, Yuichiro Doki4, Masaki Mori4, Kazuhiko Ogawa1.   

Abstract

Osteosarcoma is the most common primary bone malignancy in pediatric and adolescent populations. Recurrence and metastatic potential can be due to a subpopulation of cells with stem cell-like characteristics, such as tumor-initiating cells (TICs), which maintain the capacity to regenerate entire tumors. Targeting the TICs in osteosarcoma is a promising avenue for the development of new therapies for this devastating disease. TICs are usually quiescent with a low protein turnover, decreased metabolism, and downregulation of proteasome activity. Recently, cancer cells with low proteasome activity have been identified as TICs in several types of cancer. We stably infected two osteosarcoma cell lines, MG-63 and U2-OS, with an expression vector for a fusion protein between the green fluorescent protein, ZsGreen, and the C-terminal degron of the murine ornithine decarboxylase to monitor the 26S proteasome activity in living cells. We separated the osteosarcoma cells with low proteasome activity using fluorescence-activated cell sorting (FACS) and verified whether these ZsGreen+ cells had TIC-like properties. The ZsGreen+ cells showed enhanced sphere formation capacity and underwent asymmetric divisions into ZsGreen+ and ZsGreen- cells, whereas ZsGreen- cells underwent only symmetric divisions into ZsGreen- cells. Moreover, the ZsGreen+ cells were more chemo- and radioresistant. Thus, the present study demonstrated that chemoradiation-resistant TICs can be visualized by this system and suggested the rationale for further study of osteosarcoma stem cells.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25269626     DOI: 10.3892/ijo.2014.2671

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  15 in total

1.  The dopamine receptor antagonist trifluoperazine prevents phenotype conversion and improves survival in mouse models of glioblastoma.

Authors:  Kruttika Bhat; Mohammad Saki; Erina Vlashi; Fei Cheng; Sara Duhachek-Muggy; Claudia Alli; Garrett Yu; Paul Medina; Ling He; Robert Damoiseaux; Matteo Pellegrini; Nathan R Zemke; Phioanh Leia Nghiemphu; Timothy F Cloughesy; Linda M Liau; Harley I Kornblum; Frank Pajonk
Journal:  Proc Natl Acad Sci U S A       Date:  2020-05-01       Impact factor: 11.205

2.  Mebendazole Potentiates Radiation Therapy in Triple-Negative Breast Cancer.

Authors:  Le Zhang; Milana Bochkur Dratver; Taha Yazal; Kevin Dong; Andrea Nguyen; Garrett Yu; Amy Dao; Michael Bochkur Dratver; Sara Duhachek-Muggy; Kruttika Bhat; Claudia Alli; Frank Pajonk; Erina Vlashi
Journal:  Int J Radiat Oncol Biol Phys       Date:  2018-09-07       Impact factor: 7.038

Review 3.  Sustained proliferation in cancer: Mechanisms and novel therapeutic targets.

Authors:  Mark A Feitelson; Alla Arzumanyan; Rob J Kulathinal; Stacy W Blain; Randall F Holcombe; Jamal Mahajna; Maria Marino; Maria L Martinez-Chantar; Roman Nawroth; Isidro Sanchez-Garcia; Dipali Sharma; Neeraj K Saxena; Neetu Singh; Panagiotis J Vlachostergios; Shanchun Guo; Kanya Honoki; Hiromasa Fujii; Alexandros G Georgakilas; Alan Bilsland; Amedeo Amedei; Elena Niccolai; Amr Amin; S Salman Ashraf; Chandra S Boosani; Gunjan Guha; Maria Rosa Ciriolo; Katia Aquilano; Sophie Chen; Sulma I Mohammed; Asfar S Azmi; Dipita Bhakta; Dorota Halicka; W Nicol Keith; Somaira Nowsheen
Journal:  Semin Cancer Biol       Date:  2015-04-17       Impact factor: 15.707

4.  PK-M2-mediated metabolic changes in breast cancer cells induced by ionizing radiation.

Authors:  Le Zhang; Justine Bailleul; Taha Yazal; Kevin Dong; David Sung; Amy Dao; Laura Gosa; David Nathanson; Kruttika Bhat; Sara Duhachek-Muggy; Claudia Alli; Milana Bochkur Dratver; Frank Pajonk; Erina Vlashi
Journal:  Breast Cancer Res Treat       Date:  2019-08-01       Impact factor: 4.872

5.  Radiation-Induced Dedifferentiation of Head and Neck Cancer Cells Into Cancer Stem Cells Depends on Human Papillomavirus Status.

Authors:  Erina Vlashi; Allen M Chen; Sabrina Boyrie; Garrett Yu; Andrea Nguyen; Philip A Brower; Clayton B Hess; Frank Pajonk
Journal:  Int J Radiat Oncol Biol Phys       Date:  2016-01-14       Impact factor: 7.038

6.  A Trans-omics Mathematical Analysis Reveals Novel Functions of the Ornithine Metabolic Pathway in Cancer Stem Cells.

Authors:  Jun Koseki; Hidetoshi Matsui; Masamitsu Konno; Naohiro Nishida; Koichi Kawamoto; Yoshihiro Kano; Masaki Mori; Yuichiro Doki; Hideshi Ishii
Journal:  Sci Rep       Date:  2016-02-11       Impact factor: 4.379

Review 7.  Getting to the heart of the matter in cancer: Novel approaches to targeting cancer stem cells.

Authors:  Hugh Colvin; Masaki Mori
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2017       Impact factor: 3.493

Review 8.  Metabolic enzymes: key modulators of functionality in cancer stem-like cells.

Authors:  Bo-Wen Dong; Guang-Ming Qin; Yan Luo; Jian-Shan Mao
Journal:  Oncotarget       Date:  2017-02-21

9.  Computational trans-omics approach characterised methylomic and transcriptomic involvements and identified novel therapeutic targets for chemoresistance in gastrointestinal cancer stem cells.

Authors:  Masamitsu Konno; Hidetoshi Matsui; Jun Koseki; Ayumu Asai; Yoshihiro Kano; Koichi Kawamoto; Naohiro Nishida; Daisuke Sakai; Toshihiro Kudo; Taroh Satoh; Yuichiro Doki; Masaki Mori; Hideshi Ishii
Journal:  Sci Rep       Date:  2018-01-17       Impact factor: 4.379

10.  Enhanced proteasomal activity is essential for long term survival and recurrence of innately radiation resistant residual glioblastoma cells.

Authors:  Jacinth Rajendra; Keshava K Datta; Sheikh Burhan Ud Din Farooqee; Rahul Thorat; Kiran Kumar; Nilesh Gardi; Ekjot Kaur; Jyothi Nair; Sameer Salunkhe; Ketaki Patkar; Sanket Desai; Jayant Sastri Goda; Aliasgar Moiyadi; Amit Dutt; Prasanna Venkatraman; Harsha Gowda; Shilpee Dutt
Journal:  Oncotarget       Date:  2018-06-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.